A new investigation by the FDA indicates that the usage of e-cigarettes among teenagers is decreasing compared to pre-pandemic levels.
According to recent data released by the FDA, over 9% of middle and high school students surveyed earlier this year reported currently using e-cigarettes. Scientists warn against comparing recent years too directly due to the disruptive impact of the pandemic. A report from 2019 showed a youth e-cigarette use rate of 20%, while the number for 2020 stands at 13.1%.
From a public health perspective, this is very good news," said Jasjit Singh Ahluwalia, a professor at Brown University and tobacco expert. He added that he remains concerned about the rate of young people using e-cigarettes.
These statistics were collected as part of the National Youth Tobacco Survey, which is conducted in schools across the country annually, and then analyzed by the Centers for Disease Control and Prevention and the Food and Drug Administration.
The Centers for Disease Control and Prevention (CDC) have released a statement saying that their ability to compare estimates from 2022 with previous years is limited due to changes in survey methods caused by the pandemic. The statement also notes that the 2021 survey was conducted online and found that 7.6% of respondents reported currently using e-cigarettes. The CDC acknowledges significant changes in methodology and its impact on survey results.
However, external experts believe that in recent years, there has been a significant decline in the use of electronic cigarettes, even though these numbers cannot be directly compared.
According to Rafael Meza, a scientist at the BC Cancer Research Institute, "We still see a decrease in the number of children using e-cigarettes, despite methodological challenges, but we can draw this conclusion.
Statement:
This article has been compiled from third-party information sources and is intended solely for industry professionals for exchange and learning purposes.
This article does not necessarily reflect the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity and accuracy of the article's content. The translation of this article is solely intended for industry exchange and research purposes.
Due to limitations in translation abilities, the translated article may not completely express the same meaning as the original. Please rely on the original article for accuracy.
2FIRSTS is completely aligned with the Chinese government regarding any domestic, Hong Kong, Macau, Taiwan, or foreign affairs positions and statements.
The copyright of compiled information belongs to the original media and authors. If there is any infringement, please contact us for removal.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
